Literature DB >> 9516136

Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.

D Metes1, L K Ernst, W H Chambers, A Sulica, R B Herberman, P A Morel.   

Abstract

Human natural killer (NK) cells were thought to express only FcgammaRIIIA (CD16), but recent reports have indicated that NK cells also express a second type of FcgammaR, ie, FcgammaRII (CD32). We have isolated, cloned, and sequenced full-length cDNAs of FcgammaRII from NK cells derived from several normal individuals that may represent four different products of the FcgammaRIIC gene. One transcript (IIc1) is identical with the already described FcgammaRIIc form. The other three (IIc2-IIc4) appear to represent unique, alternatively spliced products of the same gene, and include a possible soluble form. Analyses of the full-length clones have revealed an allelic polymorphism in the first extracellular exon, resulting in either a functional open reading frame isoform or a null allele. Stable transfection experiments enabled us to determine a unique binding pattern of anti-CD32 monoclonal antibodies to FcgammaRIIc. Further analyses of NK-cell preparations revealed heterogeneity in CD32 expression, ranging from donors lacking CD32 expression to donors expressing high levels of CD32 that were capable of triggering cytotoxicity. Differences in expression were correlated with the presence or absence of null alleles. These data show that certain individuals express high levels of functional FcgammaRIIc isoforms on their NK cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516136

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  CD28 is not directly involved in the response of human CD3- CD56+ natural killer cells to lipopolysaccharide: a role for T cells.

Authors:  M R Goodier; M Londei
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

Review 3.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

Review 4.  Regulation of antibody effector functions through IgG Fc N-glycosylation.

Authors:  Isaak Quast; Benjamin Peschke; Jan D Lünemann
Journal:  Cell Mol Life Sci       Date:  2016-09-17       Impact factor: 9.261

5.  Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival.

Authors:  Gerhard Opelz; Kenneth G C Smith; Menna R Clatworthy; Rebeccah J Matthews; Bernd Doehler; Lisa C Willcocks
Journal:  Transplantation       Date:  2014-08-15       Impact factor: 4.939

6.  FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.

Authors:  Julien Lejeune; Benoît Piègu; Valérie Gouilleux-Gruart; Marc Ohresser; Hervé Watier; Gilles Thibault
Journal:  MAbs       Date:  2012-10-02       Impact factor: 5.857

7.  Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.

Authors:  Shivani Srivastava; David Pelloso; Hailin Feng; Larry Voiles; David Lewis; Zdenka Haskova; Margaret Whitacre; Stephen Trulli; Yi-Jiun Chen; John Toso; Zdenka L Jonak; Hua-Chen Chang; Michael J Robertson
Journal:  Cancer Immunol Immunother       Date:  2013-04-19       Impact factor: 6.968

Review 8.  The role of Fc receptors in HIV infection and vaccine efficacy.

Authors:  Sarah L Cocklin; Joern E Schmitz
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

9.  The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Authors:  M B Callanan; P Le Baccon; P Mossuz; S Duley; C Bastard; R Hamoudi; M J Dyer; G Klobeck; R Rimokh; J J Sotto; D Leroux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

10.  Humanised IgG1 antibody variants targeting membrane-bound carcinoembryonic antigen by antibody-dependent cellular cytotoxicity and phagocytosis.

Authors:  S Q Ashraf; P Umana; E Mössner; T Ntouroupi; P Brünker; C Schmidt; J L Wilding; N J Mortensen; W F Bodmer
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.